NASDAQ:BIB   ProShares Ultra Nasdaq Biotechnology
4
Industry: Biotechnology
EPS due date: n/a, ETF
Horizontal S&R: some
Channel S&R: no
MA S&R: some, 20ma
>200ma: yes
Volume confirmation: no
Candle Confirmation: no
Stoch Divergence: no
Reg Trendline >85: no
Short Float: no
Risk / Reward: 1.2
Any feedback is welcomed.

Kind of a neutral setup. But its a beaten up sector, maybe time to bounce.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。